期刊文献+

吡唑衍生物体外抗肿瘤活性研究 被引量:1

Anti-tumor activities of pyrazole derivatives in vitro
下载PDF
导出
摘要 目的:研究吡唑衍生物对PC3、Bcap37、BGC8233种肿瘤细胞株生长的影响及其作用机制。方法:采用MTT比色法测定吡唑衍生物对3种肿瘤细胞生长的影响;AO/EB双染色,荧光显微镜观察细胞凋亡形态;利用Western Blot检测化合物对蛋白激酶磷酸化的影响。结果:吡唑衍生物对3种肿瘤细胞生长有一定的抑制作用,且具有浓度依赖性;吖啶橙/溴化乙锭(AO/EB)双染色可见吡唑衍生物F分别使PC3细胞变小、变圆,核染色质凝集,Bcap37细胞周围呈现亮绿色的荧光凋亡小体;WesternBlot检测可知吡唑衍生物对EGF诱导的Erk1/2磷酸化没有抑制效果。结论:吡唑衍生物对3种肿瘤细胞生长有抑制作用,化合物F诱导PC3和Bcap37细胞凋亡,吡唑衍生物不能通过阻断Erk1/2磷酸化来抑制细胞增殖。 Objective:To investigate the anti-tumor activities of pyrazole derivatives against PC3, Bcap37 and BGC823 cells,and the mechanism of action. Methods: The inhibition effects of pyrazole derivatives on PC3, Beap37 and BGC823 cells in vitro were tested through MTT colorimetric assay and the apoptotic morphology was observed by staining the PC3 cells with AO/EB. The inhibition effects of the compounds on the phosphorylation of Erk1/2 were determined by Western Blot analysis. Results: Pyrazole derivatives showed inhibition activities against PC3, Beap37 and BGC823 cells in a concentration dependent manner; compound F could induce the apoptosis of PC3 and Bcap37 cells;Western Blot analysis showed that pyrazole derivatives could not inhibit the phosphorylation of Erk1/ 2 induced by EGF. Conclusions: Pyrazole derivatives can inhibit the activities of PC3, Bcap37 and BGC823 cells, and compound F may induce the apoptosis of PC3 and Bcap37 cells ;pyrazole derivatives can not inhibit the proliferation of PC3 cell through Erk1/2 mediated signal oathway.
出处 《蚌埠医学院学报》 CAS 2009年第7期563-565,共3页 Journal of Bengbu Medical College
关键词 肿瘤/化学诱导 吡唑类衍生物 肿瘤 实验性 细胞株 凋亡 neoplasms/chemi cally induced pyrazole derivatives neoplasms, experimental cell line apoptosis
  • 相关文献

参考文献6

二级参考文献32

  • 1张志强,田志刚.MTT法检测NK和LAK活性的方法学探讨[J].中国实验临床免疫学杂志,1994,6(3):12-16. 被引量:39
  • 2汪承亚,盛瑞兰.细胞凋亡与肿瘤[J].国外医学(生理病理科学与临床分册),1996,16(4):291-293. 被引量:3
  • 3Walter LB. Interleukin-6 delays neutrophil apoptosis via a mechanism involving platelet-activating factor[J]. J Trauma, 1996,40(4) :575.
  • 4Piccip P,Ferrari S, Bacci G,et al. Treatment recommendations for osteosarcomas[J]. Drug, 1994,47:82.
  • 5Rosen G,Tan C, Sanmaneechai A,et al. The rationale for mutiple drug chemotherapy in the teeatment of osteosarcoma[J]. Cancer, 1975,35 (3 Supple) : 936.
  • 6Bacci G,Picci P,Ruggieri P, et al. Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy)for osteosarcoma of the extremities. The istituto Rizzoli experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses)and intraarterial cisplatin[J]. Cancer, 1990,65 : 25.
  • 7汪承亚,Chin Med J,1996年,109卷,537页
  • 8VALESINI G,BARONE F,BOMPANE D,et al.Advances in immunology and rheumatoid arthritis pathogenesis[J].Reumatismo,2004,56(1 Suppl 1):9-20.
  • 9MUKAI J,HACHIYA T,SUVANTO P,et al.NADE,a p75 NTR-associated cell death executor,is involved in signal transduction mediated by the common neurotrophin recep tor p75 NTR[J].J Biol Chem,2000,275(23):17566-17570.
  • 10FIRESTEIN G S.Invasive fibroblast-like synoviocytes in rheumatoid arthritis:passive responders or transformed aggressors[J].Arthritis Rheum,1996,39(11):1781-1790.

共引文献132

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部